Thermo Fisher Scientific Inc. (NYSE:TMO) agreed to acquire Australian lab supplies provider Lomb Scientific for an undisclosed amount, in a bid to widen its footprint in Asia and the Middle East.
Taren Point, New South Wales-based Lomb employs about 100 workers and posted sales of $34 million AUD last year (about $27 million in U.S. dollars).
Thermo Fisher CEO Marc Casper said the deal is part of his company’s push into overseas markets.
The Top-Rated Orthopedic Surgery Centers in the Houston Area and Beyond
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.
The addition of Lomb Scientific reinforces our commitment to expand in growing Asia Pacific markets,” Casper said in prepared remarks. “Through this acquisition, we would significantly strengthen our laboratory product offerings in the region, particularly chemicals used in life sciences, research and industrial applications. Lomb Scientific would also expand our customer base, increasing our depth of capabilities in health sciences, such as pathology, and building on our presence in strong industrial markets, such as mining.”
Thermo Fisher said it plans to integrate Lomb into its laboratory products and services and analytical technologies segments.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
5 Major Trends Emerging in Healthcare Benefits in 2025
Employees who enjoy their benefits are more inclined to stay with their company. A 2025 Marsh McLennan Agency report said 73% of employees would remain if plan options were better.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.